Novosibirsk · Russian-qualified counsel Recognised by Pravo-300 · Best Lawyers · Kommersant
Cross-border Disputes

Advised foreign investor on interim measures and asset preservation in Russia in the pharmaceuticals sector — claim dismissed

Vitaliy Vetrov · February 2026 · 3 min read

Swiss investor's Russian pharmaceutical assets released after interim measures contested and underlying claim dismissed. 14-month matter. Make an enquiry.

Interim Measures & Asset Preservation — Russia, Switzerland — Pharmaceuticals sector, arbitration-related proceedings, dismissal of claim

Client. A Swiss-registered holding company with a direct equity stake in a Russian pharmaceutical distribution entity operating across multiple federal districts.

Background. The client became the respondent in commercial proceedings in which the opposing party sought interim measures before a Russian arbitrazh court, targeting assets held by the client's Russian subsidiary — including registered intellectual property and inventory in bonded storage. The application raised procedural questions specific to Russia's pharmaceutical licensing regime, including whether assets subject to a state distribution permit could be frozen without regulatory clearance. The matter required coordinated handling across the Russian court process and the client's Swiss counsel, who were managing parallel aspects of the underlying dispute.

Our role. Counsel appeared before the arbitrazh court to contest the interim measures application, advancing arguments on the disproportionality of the proposed freeze relative to the claimed exposure and on the licensing constraints that would have rendered the preserved assets commercially inoperable pending proceedings. Counsel also coordinated directly with the client's Swiss legal team to align the Russian procedural strategy with the broader dispute timetable.

Outcome. Claim dismissed – interim measures discharged; client's Russian-registered assets released from preservation order. Following dismissal of the underlying claim, all preservation orders were formally lifted. The client's pharmaceutical distribution operations resumed without interruption to its regulatory standing in Russia. The matter concluded approximately 14 months from the date of the initial interim measures application.

Discuss a similar matter – info@vetrovpartners.com

Practitioner note

This briefing is general information and does not constitute legal advice. For advice on a specific matter, write in confidence to info@vetrovpartners.com.

Facing a matter like this?

Our team advises foreign clients on exactly these questions across Russia and the EAEU region. Initial 30-minute consultation — complimentary.

Make an enquiry